Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP754840.RA4IAKMWPpcGUK6MVNNHOAkF35LoAY2-czpKpllK_nzbg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP754840.RA4IAKMWPpcGUK6MVNNHOAkF35LoAY2-czpKpllK_nzbg130_assertion type Assertion NP754840.RA4IAKMWPpcGUK6MVNNHOAkF35LoAY2-czpKpllK_nzbg130_head.
- NP754840.RA4IAKMWPpcGUK6MVNNHOAkF35LoAY2-czpKpllK_nzbg130_assertion description "[Further, we document here the efficacy of leptin replenishment in vivo, especially by supplying it to the hypothalamus with the aid of gene therapy, in preventing the antecedent pathophysiological sequalae--hyperinsulinemia, insulin resistance and hyperglycemia--in various animal models and clinical paradigms of diabetes type 1 and 2 with or without attendant obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754840.RA4IAKMWPpcGUK6MVNNHOAkF35LoAY2-czpKpllK_nzbg130_provenance.
- NP754840.RA4IAKMWPpcGUK6MVNNHOAkF35LoAY2-czpKpllK_nzbg130_assertion evidence source_evidence_literature NP754840.RA4IAKMWPpcGUK6MVNNHOAkF35LoAY2-czpKpllK_nzbg130_provenance.
- NP754840.RA4IAKMWPpcGUK6MVNNHOAkF35LoAY2-czpKpllK_nzbg130_assertion SIO_000772 19647774 NP754840.RA4IAKMWPpcGUK6MVNNHOAkF35LoAY2-czpKpllK_nzbg130_provenance.
- NP754840.RA4IAKMWPpcGUK6MVNNHOAkF35LoAY2-czpKpllK_nzbg130_assertion wasDerivedFrom befree-2016 NP754840.RA4IAKMWPpcGUK6MVNNHOAkF35LoAY2-czpKpllK_nzbg130_provenance.
- NP754840.RA4IAKMWPpcGUK6MVNNHOAkF35LoAY2-czpKpllK_nzbg130_assertion wasGeneratedBy ECO_0000203 NP754840.RA4IAKMWPpcGUK6MVNNHOAkF35LoAY2-czpKpllK_nzbg130_provenance.